Samsara Inc.: Form 10-Q for the period ended Oct 29, 2022
Filed with the SEC on Dec 6, 2022 and accepted by EDGAR at Dec 6, 2022, 21:11 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-10-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-07-31 to 2022-10-29 | $169.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-01-30 to 2022-10-29 | $466.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-07-31 to 2022-10-29 | $47.3m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2022-01-30 to 2022-10-29 | $131.1m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2022-07-31 to 2022-10-29 | $122.5m | us-gaap:GrossProfit |
| Gross profit | 9 months2022-01-30 to 2022-10-29 | $334.8m | us-gaap:GrossProfit |
| Research and development | 3 months2022-07-31 to 2022-10-29 | $50.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-01-30 to 2022-10-29 | $132.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2022-07-31 to 2022-10-29 | −$63.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-01-30 to 2022-10-29 | −$199.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-07-31 to 2022-10-29 | $692.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-01-30 to 2022-10-29 | $1.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-07-31 to 2022-10-29 | −$58.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-01-30 to 2022-10-29 | −$193.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-07-31 to 2022-10-29 | −$0.11 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-01-30 to 2022-10-29 | −$0.38 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-07-31 to 2022-10-29 | −$0.11 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-01-30 to 2022-10-29 | −$0.38 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-07-31 to 2022-10-29 | 516,551,258 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-01-30 to 2022-10-29 | 511,867,718 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-01-30 to 2022-10-29 | −$98.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-01-30 to 2022-10-29 | $27.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2022-01-30 to 2022-10-29 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-10-29 | $447.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-10-29 | $963.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-10-29 | $1.55bn | us-gaap:Assets |
| Current liabilities | At period end2022-10-29 | $377.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-10-29 | $610.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-10-29 | $939.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001642896-22-000062. Last ingested by Listed: Nov 15, 2026, 00:51 ET. Listed shows no prices and gives no investment advice.